Solventum director exercises 1,980 RSUs into stock
Solventum Corp director John H. Weiland exercised equity awards rather than trading in the open market.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Solventum Corp director John H. Weiland exercised equity awards rather than trading in the open market. On March 27, 2026, he exercised 1,980 Restricted Stock Units, each converting into one share of Solventum common stock at a stated price of $0.00 per share.
Following this RSU settlement, Weiland now directly holds 5,544 shares of Solventum common stock. The filing shows no open-market purchases or sales, only the conversion of fully vested RSUs into common shares as part of his equity compensation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,980 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,980 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock Upon settlement.
- F2. The RSUs are fully vested.
Key Figures
Key Terms
Restricted Stock Units financial
RSU financial
derivative security financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Solventum (SOLV) report for John H. Weiland?
Was the Solventum (SOLV) insider Form 4 an open-market purchase or sale?
What security types were involved in the Solventum (SOLV) Form 4 filing?
Are the Solventum (SOLV) Restricted Stock Units in this filing fully vested?
AI-generated analysis. How Rhea-AI works. Not financial advice.